ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF
申请人:Dana-Farber Cancer Institute, Inc.
公开号:EP3986407A1
公开(公告)日:2022-04-27
[EN] ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS ALLOSTÉRIQUES D'EGFR ET LEURS PROCÉDÉS D'UTILISATION
申请人:DANA FARBER CANCER INST INC
公开号:WO2020257632A1
公开(公告)日:2020-12-24
The disclosure relates to compounds that act as an allosteric inhibitors of epidermal growth factor receptor (EGFR); pharmaceutical compositions comprising the compounds; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases.